Clicky

Grifols SA Pref(0RDV)

Description: Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum"from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring"to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.


Keywords: Medicine Disease Infectious Diseases Medical Device Healthcare Providers Ibex 35 Diagnostic Products Therapeutic Products Hemophilia Health Systems Medical Diagnosis Blood Bank Intravenous Therapy Grifols Non Biological Pharmaceutical Products Biological Materials Healthcare Continuum Pharmaceutical And Diagnostic Products Technology Collaboration Agreement

Home Page: www.grifols.com

Avinguda de la Generalitat, 152
Barcelona, 08174
Spain
Phone: 34 93 571 02 21


Officers

Name Title
Mr. Steven Francis Mayer J.D. Exec. Chairman
Mr. Raimon Grifols Roura Co-CEO & Exec. Director
Mr. Víctor Grifols Deu Co-CEO & Exec. Director
Mr. Alfredo Arroyo Guerra CFO & VP
Mrs. Eva Bastida Tubau Corp. VP and Director of Scientific & Medical Affairs
Ms. Nuria Pascual Lapeña VP of Corp. Treasury, Risk Management Investor Relation & Sustainability Officer
Mr. David Ian Bell Gen. Counsel & Chief Corp. Devel. Officer
Mr. Mateo Florencio Borrás Humbert Corp. VP & Chief HR Officer
Ms. Maria Teresa-Rioné Llano Chief Communications Officer
Ms. Montserrat Gaja Llamas Chief HR Officer

Exchange: IL

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: Euro (€)

Forward PE: 13.3869
Trailing PE: 84.35
Price-to-Book MRQ: 0.805
Price-to-Sales TTM: 1.1687
IPO Date:
Fiscal Year End: December
Full Time Employees: 27584
Back to stocks